The AABB website is currently experiencing technical issues related to login and SSO. Thank you for your patience as we work to get this resolved. If you need immediate assistance, please contact us.
Blood transfusion is a medical therapy that can be life-saving. As with any treatment, however, transfusion of blood or blood components must be ordered and administered safely and appropriately. Transfusion is more than a single discrete event—it is a process. The transfusion chain begins with donor considerations (whether their donation is safe for them to make and whether the donation is safe for any patient to receive). Once blood is collected, the safety of the blood product is a focus of activity (infectious disease testing, compatibility testing, necessary modifications such as irradiation or leukocyte reduction). The endpoint of the transfusion process involves recipient considerations (proper identification of the unit and the patient, appropriateness of blood as the best treatment modality, administration of the unit, evaluation of the recipient).
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide.
©2022 All Rights Reserved. AABB - Association for the Advancement of Blood & Biotherapies
Web Design and Development by Matrix Group International, Inc.